ANDA 87621, held by Gd Searle LLC. Aminophylline.
As of Nov 15, 2026, ANDA 87621 (Aminophyllin), held by Gd Searle LLC, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Aminophyllin25MG/ML ยท injectable;injection | Aminophylline | DiscontinuedReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
